Keros Therapeutics Financial Overview
Keros Therapeutics's market cap is currently $660.81M. The company's EPS TTM is $-0.18; its P/E ratio is 13.94; Keros Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
